These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8613913)

  • 1. Activation of ATP-dependent K+ channels and inhibition of insulin release: effect of BPDZ 62.
    Lebrun P; Antoine MH; Ouedraogo R; Kane C; Dunne M; Hermann M; Herchuelz A; Masereel B; Delarge J; de Tullio P; Pirotte B
    J Pharmacol Exp Ther; 1996 Apr; 277(1):156-62. PubMed ID: 8613913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pyridothiadiazine (BPDZ 44) as a new and potent activator of ATP-sensitive K+ channels.
    Pirotte B; Antoine MH; de Tullio P; Hermann M; Herchuelz A; Delarge J; Lebrun P
    Biochem Pharmacol; 1994 Apr; 47(8):1381-6. PubMed ID: 8185645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release.
    Lebrun P; Arkhammar P; Antoine MH; Nguyen QA; Hansen JB; Pirotte B
    Diabetologia; 2000 Jun; 43(6):723-32. PubMed ID: 10907118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic and secretory effects of BPDZ 44 and diazoxide in rat pancreatic islets.
    Antoine MH; Pirotte B; Hermann M; de Tullio P; Delarge J; Herchuelz A; Lebrun P
    Experientia; 1994 Sep; 50(9):830-2. PubMed ID: 7925849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
    Cosgrove KE; Antoine MH; Lee AT; Barnes PD; de Tullio P; Clayton P; McCloy R; De Lonlay P; Nihoul-Fékété C; Robert JJ; Saudubray JM; Rahier J; Lindley KJ; Hussain K; Aynsley-Green A; Pirotte B; Lebrun P; Dunne MJ
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets.
    Lebrun P; Devreux V; Hermann M; Herchuelz A
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1011-8. PubMed ID: 2506332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil, a phenylalkylamine Ca2+ channel blocker, inhibits ATP-sensitive K+ channels in insulin-secreting cells from rats.
    Lebrun P; Antoine MH; Ouedraogo R; Pirotte B; Herchuelz A; Cosgrove KE; Kane C; Dunne MJ
    Diabetologia; 1997 Dec; 40(12):1403-10. PubMed ID: 9447947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
    Garrino MG; Plant TD; Henquin JC
    Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pinacidil inhibits insulin release by increasing K+ outflow from pancreatic B-cells.
    Lebrun P; Devreux V; Hermann M; Herchuelz A
    Eur J Pharmacol; 1988 Nov; 156(2):283-6. PubMed ID: 3071468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K(+) channels in endocrine and smooth muscle tissues.
    Becker B; Antoine MH; Nguyen QA; Rigo B; Cosgrove KE; Barnes PD; Dunne MJ; Pirotte B; Lebrun P
    Br J Pharmacol; 2001 Sep; 134(2):375-85. PubMed ID: 11564656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-alkyl-3-Alkylamino-2H-Benzo- and pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers?
    Ouedraogo R; Becker B; Boverie S; Somers F; Antoine MH; Pirotte B; Lebrun P; de Tullio P
    Biol Chem; 2002 Nov; 383(11):1759-68. PubMed ID: 12530541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxylamine, a nitric oxide donor, inhibits insulin release and activates K+ATP channels.
    Antoine MH; Ouedraogo R; Sergooris J; Hermann M; Herchuelz A; Lebrun P
    Eur J Pharmacol; 1996 Oct; 313(3):229-35. PubMed ID: 8911919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pinacidil, RP 49356 and nicorandil on ATP-sensitive potassium channels in insulin-secreting cells.
    Dunne MJ
    Br J Pharmacol; 1990 Mar; 99(3):487-92. PubMed ID: 2158844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium nitroprusside inhibits glucose-induced insulin release by activating ATP-sensitive K+ channels.
    Antoine MH; Hermann M; Herchuelz A; Lebrun P
    Biochim Biophys Acta; 1993 Feb; 1175(3):293-301. PubMed ID: 8435446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilative properties of BPDZ 79, a new potassium channel opener, in isolated aorta.
    Fang ZY; Fontaine J
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):101-4. PubMed ID: 10072956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
    Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
    Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that glucose can control insulin release independently from its action on ATP-sensitive K+ channels in mouse B cells.
    Gembal M; Gilon P; Henquin JC
    J Clin Invest; 1992 Apr; 89(4):1288-95. PubMed ID: 1556189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria.
    Grimmsmann T; Rustenbeck I
    Br J Pharmacol; 1998 Mar; 123(5):781-8. PubMed ID: 9535004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical inhibitory effect of cromakalim on 86Rb outflow from pancreatic islet cells.
    Lebrun P; Antoine MH; Devreux V; Hermann M; Herchuelz A
    J Pharmacol Exp Ther; 1990 Dec; 255(3):948-54. PubMed ID: 2124624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tacrine on insulin secretion and 86Rb+ and 45Ca++ efflux from rat pancreatic islets.
    Karlsson S; Ahrén B
    J Pharmacol Exp Ther; 1992 Nov; 263(2):494-8. PubMed ID: 1331400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.